Effect of Cross-legged Sitting Among Patients With Unilateral Hip Developmental Dysplasia

NCT ID: NCT07002840

Last Updated: 2025-06-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-05

Study Completion Date

2025-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

One of the most common infant developmental diseases is Hip dysplasia which is mostly seen among female' babies and leads to hip instability due to partial or full hip dislocation \[1\]. Physical therapy's role plays a significant role in treating hip dysplasia by creating new walking habits as an adaptation way and compensation for the deformity \[3\]. Focusing on the muscles that produce hip abduction force is a basic item of the hip dysplasia rehabilitation program \[4\]. Cross-legged sitting position can be considered as a common and easy position that might enhance the range of motion of the lower limb joints \[5\].

While unilateral hip developmental dysplasia has been widely distributed among newborns, especially in the last few years, the role of engaging the cross-legged sitting technique as a part of physical therapy and rehabilitation programs on improving the temporospatial parameters, muscular electrical activity and foot pressure distributing is still not clear. Therefore, this study aimed to analyze the effects of engaging the cross-legged sitting technique as a part of physical therapy and rehabilitation program among patients with UHDD by comparing the group who participated in rehabilitation program with CLS to the other without.

To understand the importance of including Cross-legged sitting technique in physical therapy and rehabilitation program of Unilateral Hip Developmental Dysplasia (UHDD) to enhance the spatial and temporal measures, achieving a healthy distribution of foot pressure, increasing the electrical activity of lower limb muscles and improving the overall gait pattern.

No risks at all. All instruments and techniques in this study are safe and used regularly without any hazards.

The data will be stored and archived on a password-protected computer for safety and security purposes. After accomplishing the research and getting the outcomes, the results of the research may be published as an academic article in a peer-reviewed journal. In another word, no personal data will be published at all.

Taking part in the study and withdrawing at any time is completely voluntary with no need to give any reason.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Developmental Dysplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DDH kids who participated in rehabilitation programs with CLS

The study sample includes kids with DDH who participated in rehabilitation programs with CLS.

Group Type EXPERIMENTAL

Cross- legged sitting position

Intervention Type OTHER

CLS in which the legs were crossed with hip and knee joints flexed

Physical Therapy Rehabilitation Program

Intervention Type OTHER

Strengthening Exercises Stretching Exercises Range of Motion Exercises

DDH kids who participated in usual rehabilitation programs without CLS

The study sample includes kids with DDH who participated in rehabilitation programs without CLS.

Group Type ACTIVE_COMPARATOR

Physical Therapy Rehabilitation Program

Intervention Type OTHER

Strengthening Exercises Stretching Exercises Range of Motion Exercises

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cross- legged sitting position

CLS in which the legs were crossed with hip and knee joints flexed

Intervention Type OTHER

Physical Therapy Rehabilitation Program

Strengthening Exercises Stretching Exercises Range of Motion Exercises

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age group from 9 months to 10 years old
* all participants suffer from Unilateral Hip Developmental Dysplasia (UHDD)
* participants should be healthy in general

Exclusion Criteria

Any participant with a history of neurological disorders, lower extremities previous surgical intervention, lower limb deformities, flat feet or high body mass index will be excluded from this study
Minimum Eligible Age

9 Months

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jouf University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hadeel Saad Alsirhani

Assistant Professor of Physical Therapy

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hadeel Alsirhani, PhD

Role: CONTACT

+966556256464

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HAPO-13-S-(001)-(7371)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.